| Q53927804 | A long-term study of the efficacy and acceptability of a single-rod hormonal contraceptive implant (Implanon) in healthy women in China. |
| Q45103485 | Acceptability of the etonogestrel-containing contraceptive implant (Implanon) |
| Q42616102 | Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception |
| Q59330175 | Discontinuation rate of Implanon and its associated factors among women who ever used Implanon in Dale District, Southern Ethiopia |
| Q46738496 | Ectopic pregnancy with etonogestrel contraceptive implant (Implanon): first case |
| Q73428037 | Effects of the etonogestrel-releasing contraceptive implant (Implanon on parameters of breastfeeding compared to those of an intrauterine device |
| Q50912748 | Effects of the progestagen-only contraceptive implant Implanon on cardiovascular risk factors. |
| Q77415061 | Effects on the hemostatic system and liver function in relation to Implanon and Norplant. A prospective randomized clinical trial |
| Q34192036 | Efficacy and safety of long-acting reversible contraception |
| Q30485192 | Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive |
| Q40470645 | Global trends in use of long-acting reversible and permanent methods of contraception: Seeking a balance. |
| Q36403670 | Hormonal contraception in adolescents: special considerations |
| Q37812090 | Implanon: The Subdermal Contraceptive Implant |
| Q34191303 | Implanon: a critical review |
| Q34089771 | Implantable contraception |
| Q37360879 | In vitro and in vivo evaluations of biodegradable implants for hormone replacement therapy: effect of system design and PK-PD relationship |
| Q56765821 | Insertion and removal of Implanon |
| Q33707932 | Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: a prospective study |
| Q41006286 | Microfabrication for Drug Delivery |
| Q52942560 | Migration of a Nexplanon contraceptive implant to the pulmonary artery. |
| Q37984479 | Nexplanon: the new implant for long-term contraception. A comprehensive descriptive review. |
| Q30676041 | Nonmenstrual adverse events during use of implantable contraceptives for women: data from clinical trials |
| Q73826010 | Ovarian function during use of Nestorone(R) subdermal implants |
| Q56765819 | Pharmacokinetics of Implanon. An integrated analysis |
| Q53939359 | Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon. |
| Q38822468 | Pharmacologic treatment of the ovarian endometrioma. |
| Q42851887 | Reduced Effectiveness of Contraceptive Implants for Women Taking the Antiretroviral Efavirenz (EFV): Still Good Enough and for How Long? |
| Q35194397 | Risk-benefit effects of implantable contraceptives in women |
| Q36044419 | Role of progestins in contraception |
| Q40626949 | Sonographic imaging in progestin users and future directions |
| Q34126221 | Strategies to prevent unintended pregnancy: increasing use of long-acting reversible contraception |
| Q24243993 | Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods for preventing pregnancy |
| Q37106340 | The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience |
| Q30560500 | The pharmacodynamics and efficacy of Implanon. An overview of the data |
| Q44791664 | Treatment of endometriotic catamenial haemoptysis with etonogestrel subdermal implant |
| Q44182099 | Ultrasonographic features of the endometrium and the ovaries in women on etonogestrel implant |
| Q46586812 | Ultrasound-guided removal of Implanon devices |